Cytokinetics
CYTK
85 hedge funds and large institutions have $69.7M invested in Cytokinetics in 2014 Q3 according to their latest regulatory filings, with 9 funds opening new positions, 34 increasing their positions, 17 reducing their positions, and 13 closing their positions.
100% more repeat investments, than reductions
Existing positions increased: 34 | Existing positions reduced: 17
4% less funds holding
Funds holding: 89 → 85 (-4)
31% less capital invested
Capital invested by funds: $101M → $69.7M (-$30.8M)
31% less first-time investments, than exits
New positions opened: 9 | Existing positions closed: 13
35% less call options, than puts
Call options by funds: $561K | Put options by funds: $869K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
WA
Wasatch Advisors
Salt Lake City,
Utah
|
+$2.02M |
| 2 |
SFM
Sphera Funds Management
Tel Aviv,
Israel
|
+$1.25M |
| 3 |
Renaissance Technologies
New York
|
+$1.01M |
| 4 |
BI
BVF Inc
San Francisco,
California
|
+$882K |
| 5 |
Millennium Management
New York
|
+$840K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AWG
Alpha Wave Global
New York
|
-$8.53M |
| 2 |
Wellington Management Group
Boston,
Massachusetts
|
-$1.79M |
| 3 |
IGIM
I.G. Investment Management
Winnipeg,
Manitoba, Canada
|
-$1.36M |
| 4 |
BIM
Bogle Investment Management
Newton Lower Falls,
Massachusetts
|
-$980K |
| 5 |
DCM
Driehaus Capital Management
Chicago,
Illinois
|
-$980K |
CYTK Hedge Fund Activity: Q3 2014 in Review
85 of the 3,455 institutional investors tracked by Wall St. Rank reported a position in Cytokinetics (CYTK) for Q3 2014, worth a combined $69.7M — down 31% from $101M a quarter earlier.
Sellers outnumbered buyers: 13 funds closed out of CYTK and 9 opened new positions — a net loss of 4 holders — while 17 trimmed existing stakes and 34 added.
The largest buyer was Wasatch Advisors, adding an estimated $2.02M. The largest seller was Alpha Wave Global, exiting entirely with an estimated $8.53M sold.
- 85 institutional investors held Cytokinetics (CYTK) as of Q3 2014, down from 89 in Q2 2014.
- Funds reported $69.7M of Cytokinetics stock for Q3 2014, down 31% quarter-over-quarter.
- 9 funds opened new Cytokinetics positions in Q3 2014 and 13 closed out, a net change of -4 holders.
- The largest Cytokinetics buyer in Q3 2014 was Wasatch Advisors, an estimated $2.02M added.
- The largest Cytokinetics seller in Q3 2014 was Alpha Wave Global, an estimated $8.53M sold.
Based on aggregated 13F filings for Q3 2014.